Bordeaux Colorectal Institute

What Bordeaux Colorectal Institute does

The Bordeaux Colorectal Institute (legal entity: Institut de Chirurgie Colorectale de Bordeaux, RCS 52135541200045) is a physician-led private medical practice headquartered at Clinique Tivoli-Ducos in Bordeaux, France, self-described as the first French center entirely dedicated to colorectal pathology. It provides specialized care for colon cancer, rectal cancer, inflammatory bowel diseases (Crohn's disease, ulcerative colitis), deep endometriosis affecting the bowel, pelvic floor disorders, and abdominal wall defects. Surgical practice centers on advanced minimally invasive and organ-preserving techniques, including robotic total mesorectal excision (TME), transanal TME (TaTME), intraoperative indocyanine green fluorescence angiography (FLUOCOL-1 trial), and a Watch & Wait organ preservation pathway for rectal cancer responders, supported by a structured Day Hospital (HDJ) preoperative assessment program and a multidisciplinary team that includes surgeons, a stoma nurse (Flora Maurer), a psychologist, a dietitian, a sexology/wound care nurse, and dedicated research staff.

The institute operates an active clinical research program, participating in 98 trials to date with 18 currently ongoing—including GRECCAR 14, GRECCAR 16/NORAD, FLUOCOL-1, GRECCAR 20/PRODIGE 101-EVAREC, COLOVAC, MINIGO, OASIS, and the PROCARE register—and has produced 90 scientific publications since 2023. It runs the BCI Academy, a continuous medical education platform (founded by Pr. Quentin Denost and Philippe Francy) delivered through Invivox with a 24-member international KOL Scientific Board, plus live surgery broadcasts and clinical immersion programs that anchor an international training community. Commercial activity flows primarily through direct-to-patient consultations and surgical procedures at the Bordeaux clinic (with referrals from GPs, gastroenterologists, and oncologists, plus self-referrals via the public website and Doctolib), supplemented by fee-based training and congress activity. Strategic partnerships include IFEMENDO for endometriosis, the PelvEx Collaborative, IRCAD faculty engagement, and co-organization of the JFCCR scientific congress with GRECCAR, GETAID, SFCD, SNFCP, SFED, and SFCE.

Name

Bordeaux Colorectal Institute

Legal name

INSTITUT DE CHIRURGIE COLORECTALE DE BORDEAUX

Website

https://bordeaux-colorectal-institute.fr

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Bordeaux Colorectal Institute is a physician-led private medical practice in Bordeaux, France, delivering specialized colorectal surgery — robotic TME, TaTME, ICG fluorescence, and organ preservation — alongside clinical research and the BCI Academy international training platform.

Ownership category

akta.pro rank

Product category

Specialized Colorectal Surgery & Care

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Pancreaticobiliary Disorders (HLAKAEAG)

Keywords

• Colorectal surgery
• Rectal cancer surgery
• Inflammatory bowel disease
• Pelvic floor surgery
• Organ preservation therapy

Headquarters

HQ city

Bordeaux

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Surgical and Consultancy Services: Revenue is generated through fee-for-service medical consultations, surgical procedures, and hospitalizations billed under the French national health insurance system (Sécurité sociale) and supplementary insurance frameworks. Additional revenue derives from training programs organized through BCI Academy.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Bordeaux Colorectal Institute is the first French center entirely dedicated to colorectal pathology, delivering specialized surgical treatment for colon cancer, rectal cancer, inflammatory bowel disease, deep endometriosis, and pelvic floor disorders using robotic-assisted, laparoscopic, transanal, and open techniques. The institute operates three integrated care pathways — standard surgical hospitalization, a Day Hospital (HDJ) preoperative assessment, and an Organ Preservation (Watch & Wait) pathway — and supplements clinical care with an active research program (GRECCAR, PRODIGE, FLUOCOL trials) and the BCI Academy international medical education platform.

Product overview

Bordeaux Colorectal Institute is a specialized colorectal surgery center (the first in France entirely dedicated to colorectal pathology) offering integrated patient care, clinical research, and medical education. The core offering includes specialized colorectal surgery services for cancer, inflammatory diseases, and endometriosis using advanced techniques (robotic, laparoscopic, transanal). The institute operates three interconnected care pathways: standard surgical hospitalization, Day Hospital (HDJ) preoperative assessment, and Organ Preservation pathway forWatch & Wait strategies. BCI Academy provides international medical education through Invivox partnership. The institute conducts active clinical research through multiple trials (GRECCAR, PRODIGE, FLUOCOL) and maintains partnerships with IFEMENDO for endometriosis care.

Differentiator

Problem solved

Functional benefit

Brands

• BCI Academy: Educational and training arm of Bordeaux Colorectal Institute, offering continuous medical education programs, webinars, clinical immersion, and international conferences for colorectal surgery professionals. Founded by Pr. Quentin Denost and Philippe Francy with a Scientific Board of 24 international key opinion leaders.

Products and services

• Colorectal Surgery Services Specialized surgical treatment for colorectal conditions including colon cancer, rectal cancer, inflammatory bowel diseases (Crohn's disease, ulcerative colitis), deep endometriosis, and pelvic floor disorders. Offers multiple surgical approaches — open, laparoscopic, robotic-assisted, and transanal — for patients referred for complex colorectal pathology.
• Organ Preservation Pathway (Watch & Wait) Specialized care pathway for rectal cancer patients who achieved complete response after neoadjuvant treatment, offering the Watch & Wait strategy and local excision options to avoid major surgery while preserving the rectum. Includes multidisciplinary response assessment integrating clinical, endoscopic, and radiological evaluation under a shared decision-making framework.
• Day Hospital Surgical Pathway (HDJ) One-day preoperative assessment program in which patients consult the BCI surgeon, dietitian, psychologist, wound care nurse, and stoma care nurse in a single visit, preparing them for upcoming colorectal surgery and coordinating multidisciplinary care planning.
• Clinical Trials & Research Program Participation in multiple clinical trials (GRECCAR 14, GRECCAR 16/NORAD, GRECCAR 20/PRODIGE 101-EVAREC, FLUOCOL-1, COLOVAC, MINIGO, OASIS, PROCARE register) focused on improving colorectal cancer treatment outcomes, surgical techniques (including ICG fluorescence angiography), and patient care quality. Patients gain access to novel therapeutic strategies.
• BCI Academy International medical education and training program for colorectal surgeons worldwide, delivered online through the Invivox platform and on-site via clinical immersion at BCI. Includes webinars, podcasts, smart replays, e-clinical cases, video sessions, and in-person fellowship-style training, with a Scientific Board of 24 international key opinion leaders.
• Clinical Immersion Training Hands-on clinical immersion program hosted at BCI for international colorectal surgeons, including live robotic surgery broadcasts (in-person and remote) and on-site observation of advanced procedures such as Robotic TME and transanal surgery.
• IFEMENDO Partnership — Bowel Endometriosis Surgical Care Coordinated multidisciplinary surgical care for patients with deep endometriosis involving the bowel, delivered in partnership with IFEMENDO (an endometriosis expert center located within Clinique Tivoli). Includes shaving, discoid excision, and segmental bowel resection, with fertility and bowel function preservation as priorities.

Quantifiable outcome

• More than 490 patients with colorectal diseases managed in 2025
• +2 more outcomes

Named customers1 record

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core, major and minor.

• GRECCAR, GETAID, SFCD, SNFCP, SFED, SFCEcoreStrategic or Co-development Partner · 26 March 2026BCI Academy co-organizes the JFCCR (Journées Francophones de Chirurgie Colorectale) in collaboration with GRECCAR (French Research Group on Rectal Cancer), GETAID (French IBD research group), SFCD, SNFCP, SFED, and SFCE societies, addressing the full spectrum of colorectal pathologies through scientific sessions.
• PelvEx CollaborativemajorStrategic or Co-development Partner · 29 June 2023BCI Academy organizes the PelvEx Meeting 2023 in Bordeaux, hosting the international PelvEx Collaborative group of 200-250 highly specialized members sharing research projects and clinical innovations in complex pelvic surgeries and pelvectomies. The BCI team actively participates in this international research network.
• IFEMENDOcoreStrategic or Co-development PartnerBCI partners with IFEMENDO, a recognized expert center dedicated exclusively to endometriosis treatment located within Clinique Tivoli Bordeaux, for the surgical management of bowel (rectal/sigmoid) endometriosis. Consultations, preoperative assessment, and appointments are coordinated through IFEMENDO's platform.
• IRCAD (Institut de Recherche contre les Cancers de l'Appareil Digestif)majorTechnology or IntegrationPr. Denost serves as faculty at IRCAD Strasbourg, a world-renowned center for minimally invasive surgical training. BCI surgeons regularly intervene at IRCAD Colorectal Surgery programs to share techniques including Robotic TME and transanal surgery, contributing to the diffusion of BCI's surgical innovations.
• InvivoxmajorChannel Partner/ Reseller/ DistributorBCI Academy collaborates with Invivox to deliver continuous online surgical education globally. The platform hosts BCI Academy courses including webinars, podcasts, e-clinical cases, and video sessions across 3 cycles of 4 months per year, enabling international surgeon registration and clinical immersion access.
• St-Paul Course FacultyminorStrategic or Co-development PartnerBCI participates as invited speaker at the St-Paul Course on Digestive Cancers (Nice), presenting on shared medical decision-making in rectal cancer, maintaining visibility in the international academic circuit.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Memorial Sloan Kettering Cancer Center: US comprehensive cancer center with a leading colorectal oncology service running active organ preservation and robotic rectal surgery programs. A high-end competitor for international complex rectal cancer referrals and research collaborations.
• Charité - Universitätsmedizin Berlin: Major European academic hospital with a high-volume colorectal and visceral surgery department active in robotic, TaTME, and IBD surgery. Comparable to BCI on surgical technique and research output, with greater institutional scale and broader case mix.
• Netherlands Cancer Institute (Antoni van Leeuwenhoek): Dutch comprehensive cancer center known for surgical oncology of gastrointestinal tumors, including rectal cancer with organ preservation research. Competes with BCI for international complex rectal cancer referrals and academic visibility.
• Gustave Roussy: Leading French comprehensive cancer center with a strong gastrointestinal oncology and rectal cancer surgery program. Competes with BCI for French colorectal cancer referrals, particularly complex and locally advanced rectal cases, while operating at much larger institutional scale.
• Cleveland Clinic - Colorectal Surgery: US-based broad health system with a high-volume colorectal surgery department offering robotic and transanal techniques plus clinical research. Comparable to BCI on surgical modality and research output, but operating at substantially larger scale within a general hospital.
• Mayo Clinic - Colon and Rectal Surgery: Major US academic medical system whose Colon and Rectal Surgery department performs high-volume robotic, laparoscopic, and TaTME procedures with active organ preservation and clinical trial programs. BCI competes for international referrals and academic visibility against Mayo's center-of-excellence brand.

Regional players

• AP-HP Hôpital Saint-Antoine (Assistance Publique – Hôpitaux de Paris): Major Paris public academic hospital with a strong digestive and colorectal surgery department. Operates in the same country as BCI with comparable surgical capabilities (robotic, laparoscopic, IBD) but serves primarily the Paris/Ile-de-France catchment, making it a regional overlap rather than a direct competitor in Nouvelle-Aquitaine.

Direct peers

• St Mark's Hospital: A UK NHS foundation hospital in London historically dedicated to colorectal disease — the most analogous institutional model worldwide to BCI's positioning as a dedicated colorectal reference center. Both centers concentrate complex pelvic and rectal cancer work under multidisciplinary teams and serve as national reference points.

Others

• IRCAD (Institut de Recherche contre les Cancers de l'Appareil Digestif): World-renowned minimally invasive digestive surgery training institute in Strasbourg where Pr. Denost serves as faculty. Not a direct clinical competitor but adjacent to BCI on surgical technique dissemination and continuing education, and a BCI partner ecosystem institution.
• IFEMENDO: Bordeaux-based expert center dedicated exclusively to endometriosis, co-located with BCI at Clinique Tivoli. Listed as a strategic partner for bowel endometriosis surgery rather than a competitor, included for adjacent comparability on the endometriosis surgical pathway and co-located operating model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/bordeaux-colorectal-institute

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bordeaux Colorectal Institute